4D Molecular Therapeutics
FDMT
#8515
Rank
โ‚ฌ0.13 B
Marketcap
2,83ย โ‚ฌ
Share price
-3.14%
Change (1 day)
-87.48%
Change (1 year)

EPS for 4D Molecular Therapeutics (FDMT)

EPS in 2023 (TTM): -3,10ย โ‚ฌ

According to 4D Molecular Therapeutics's latest financial reports the company's current EPS (TTM) is -2,87ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,91ย โ‚ฌ a decrease over its 2021 EPS that were of -2,24ย โ‚ฌ.

EPS history for 4D Molecular Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-3,10ย โ‚ฌ6.63%
2022-2,91ย โ‚ฌ29.69%
2021-2,24ย โ‚ฌ-15.82%
2020-2,67ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,91ย โ‚ฌ-33.54%๐Ÿ‡บ๐Ÿ‡ธ USA